ARCHIVES

Tafinlar Subgroup Data Shows Median OS of 20 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Prevention & Control Study Section Needed: Letter to the Editor

June 11, 1993

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

In Brief: Steve Carter Accepts Job With Bristol, Phillips Elected NCG Chairman; Murray Copeland Dies

April 9, 1982

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990

Panel Resumes Deliberations

January 4, 1980